INHSU 2017

Burnet Institute Econometrician Dr Nick Scott, will present at INHSU 2017, the Sixth International Symposium of The International Network on Hepatitis in Substance Users, in New York, USA.

Dr Scott’s presentation is entitled: Reaching Hepatitis C Virus Elimination Targets Requires Health System Interventions to Enhance the Care Cascade.

Burnet will also be represented by Dr Alisa Pedrana and Dr Jacquie Richmond, who will be facilitating a workshop on enhancing ‘treatment preparedness’ through nurse-led models in community and prison settings.

Topics at INHSU 2017 include:

  • Increased coverage of harm reduction services (e.g. OST and NSP) are needed to prevent HCV and HIV for people who inject drugs, given ongoing transmission
  • In North America, the opioid crisis calls for better access to health care for people who inject drugs
  • Strategies to enhance HCV testing and diagnosis for people who inject drugs are emerging and are needed to enhance HCV direct-acting antiviral treatment
  • Treatment with direct-acting antiviral HCV therapy is safe and effective in clinical trials and the “real-world” with low rates of HCV reinfection
  • Access to direct-acting antiviral HCV therapies must be improved to enable the WHO elimination goal of eliminating HCV as a major global health threat by 2030

Find out more at the conference website.

Date & Time

Wednesday, 6 September, 2017 – Friday, 8 September, 2017


Hyatt Regency on the Hudson,
Jersey City,
New York.

Google Map

Contact Details

For more information about this event, please contact:

Doctor Nick Scott

Head, Modelling & Biostatistics Group




[email protected]